Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oncothyreon -- Ignore unavailable to you. Want to Upgrade?

To: StockMiser who wrote (926)	6/29/1999 11:44:00 AM
From: Garry K.	Read Replies (1) \| Respond to of 2344

StockMiser: My strategy with this company mimmicks yours...buying on the dips and holding on at least 18-24 months. We may see some small spikes if there are progress reports or additional milestones made on other products in the pipeline. However, I don't think we will see dramatic price appreciation until full enrollment has been made in Phase III. Institutional investors would likely wait and see until then as there is too much potential risk at the present time. I think there has been some disappointed investors who thought they may make a quick buck on this company -- it is still possible to see a good spike if there is some type of surprise. However, this is a quality hold for a patient investor. Given time, this gem will shine. Good luck! Garry

To: StockMiser who wrote (926)	6/30/1999 1:09:00 AM
From: Cal Gary	Read Replies (1) \| Respond to of 2344

Perhaps these dips maybe on relatively higher prices for the near term. May 19th, MACD signaled a sell on BRA.T. Looks like MACD may signal a buy, perhaps tomorrow. :) Slow Stoch has signaled a buy for this latest short term "mini-move" about June 17th. Relative strength picking up. :) OBV relatively flat during the recent the price decline. :)